An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia
NCT03424018
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
119
Enrollment
INDUSTRY
Sponsor class
Conditions
Achondroplasia
Interventions
DRUG:
BMN 111
Sponsor
BioMarin Pharmaceutical